Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells In Vivo and In Vitro
Clear cell renal cell carcinoma (ccRCC) is the most aggressive urologic tumor, and its incidence and diagonosis have been continuously increasing. Identifying novel molecular biomarker for inhibiting the progression of ccRCC will facilitate developing new treatment strategies. Although methyltransfe...
Main Authors: | Wei Li, Shi Xu, Naixiong Peng, Zejian Zhang, Hua He, Ruoyu Chen, Dong Chen, Jiqing Fan, Xisheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.634542/full |
Similar Items
-
The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma
by: Chen, J., et al.
Published: (2022) -
Esculetin inhibits proliferation, migration, and invasion of clear cell renal cell carcinoma cells
by: Junyao Duan, et al.
Published: (2020-05-01) -
TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients’ survival
by: Xiao W, et al.
Published: (2018-11-01) -
MiR‐483‐5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma
by: Xue‐Gang Wang, et al.
Published: (2021-03-01) -
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
by: Laura K. Esser, et al.
Published: (2020-09-01)